DelveInsight has launched a new report on “Psoriatic Arthritis – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Psoriatic Arthritis – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
According to a study, almost a third of patients with psoriasis seen in dermatology centers had PsA as determined by rheumatologists.
According to a study of German healthcare insurance data, PsA had prevalence rates of 0.3% respectively, in 2016.
Psoriatic Arthritis was identified in 431 of 3021 patients with psoriasis, with a mean prevalence of 14.3% (range, 8.8–20.4%) in Japan.
Key benefits of the report:
Psoriatic Arthritis market report covers a descriptive overview and comprehensive insight of the Psoriatic Arthritis epidemiology and Psoriatic Arthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Psoriatic Arthritis market report provides insights on the current and emerging therapies.
Psoriatic Arthritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Psoriatic Arthritis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Psoriatic Arthritis market.
Got queries? Click here to know more about the Psoriatic Arthritis Market Landscape.
Psoriatic Arthritis Overview
Psoriatic Arthritis is a sort of arthritis that affects some people with psoriasis. Most people develop psoriasis first and are later diagnosed with psoriatic arthritis, but joint problems can sometimes begin before skin patches appear.
The key players involved in the Psoriatic Arthritis market:
The launch of the emerging therapies is expected to significantly impact the Psoriatic Arthritis treatment scenario in the upcoming years:-
Skyrizi and Rinvoq
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Psoriatic Arthritis Patient Share (%) Overview at a Glance
5. Psoriatic Arthritis Market Overview at a Glance
6. Psoriatic Arthritis Disease Background and Overview
7. Psoriatic Arthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Psoriatic Arthritis
9. Psoriatic Arthritis Current Treatment and Medical Practices
10. Unmet Needs
11. Psoriatic Arthritis Emerging Therapies
12. Psoriatic Arthritis Market Outlook
13. Country-Wise Psoriatic Arthritis Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Psoriatic Arthritis Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
“Psoriatic Arthritis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Psoriatic Arthritis market. A detailed picture of the Psoriatic Arthritis pipeline landscape is provided, which includes the disease overview and Psoriatic Arthritis treatment guidelines.
DelveInsight’s ‘Psoriatic Arthritis Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Psoriatic Arthritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States